Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
CNY 5.64
(-1.4%)
CNY 5.64
(-1.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.33 Billion CNY | 1.99% |
| 2022 | 2.29 Billion CNY | 8.51% |
| 2021 | 2.11 Billion CNY | 11.79% |
| 2020 | 1.88 Billion CNY | 0.3% |
| 2019 | 1.88 Billion CNY | 4.7% |
| 2018 | 1.79 Billion CNY | 5.76% |
| 2017 | 1.7 Billion CNY | 1.55% |
| 2016 | 1.67 Billion CNY | 21.3% |
| 2015 | 1.38 Billion CNY | 0.92% |
| 2014 | 1.36 Billion CNY | 3.45% |
| 2013 | 1.32 Billion CNY | 26.9% |
| 2012 | 1.04 Billion CNY | 11.0% |
| 2011 | 938.59 Million CNY | -1.0% |
| 2010 | 948.05 Million CNY | 283.52% |
| 2009 | 247.19 Million CNY | 15.01% |
| 2008 | 214.92 Million CNY | 23.34% |
| 2007 | 174.25 Million CNY | -17.7% |
| 2006 | 211.73 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.39 Billion CNY | 2.3% |
| 2024 Q2 | 2.45 Billion CNY | 2.64% |
| 2024 Q3 | 2.45 Billion CNY | -0.02% |
| 2023 Q4 | 2.33 Billion CNY | 2.94% |
| 2023 Q2 | 2.27 Billion CNY | -3.8% |
| 2023 Q1 | 2.36 Billion CNY | 3.39% |
| 2023 Q3 | 2.26 Billion CNY | -0.39% |
| 2023 FY | 2.33 Billion CNY | 1.99% |
| 2022 Q2 | 2.2 Billion CNY | 3.36% |
| 2022 Q1 | 2.13 Billion CNY | 1.0% |
| 2022 FY | 2.29 Billion CNY | 8.51% |
| 2022 Q4 | 2.29 Billion CNY | -1.54% |
| 2022 Q3 | 2.32 Billion CNY | 5.57% |
| 2021 FY | 2.11 Billion CNY | 11.79% |
| 2021 Q2 | 2.03 Billion CNY | 6.07% |
| 2021 Q4 | 2.11 Billion CNY | 3.3% |
| 2021 Q1 | 1.92 Billion CNY | 1.73% |
| 2021 Q3 | 2.04 Billion CNY | 0.29% |
| 2020 Q2 | 1.81 Billion CNY | -6.56% |
| 2020 FY | 1.88 Billion CNY | 0.3% |
| 2020 Q3 | 1.83 Billion CNY | 1.37% |
| 2020 Q1 | 1.94 Billion CNY | 3.1% |
| 2020 Q4 | 1.88 Billion CNY | 2.71% |
| 2019 Q2 | 1.84 Billion CNY | 0.69% |
| 2019 Q3 | 1.89 Billion CNY | 2.56% |
| 2019 FY | 1.88 Billion CNY | 4.7% |
| 2019 Q1 | 1.83 Billion CNY | 2.08% |
| 2019 Q4 | 1.88 Billion CNY | -0.68% |
| 2018 Q4 | 1.79 Billion CNY | 0.34% |
| 2018 Q1 | 1.73 Billion CNY | 1.98% |
| 2018 Q3 | 1.79 Billion CNY | 4.79% |
| 2018 Q2 | 1.71 Billion CNY | -1.37% |
| 2018 FY | 1.79 Billion CNY | 5.76% |
| 2017 Q2 | 1.66 Billion CNY | -1.49% |
| 2017 Q4 | 1.7 Billion CNY | 0.33% |
| 2017 FY | 1.7 Billion CNY | 1.55% |
| 2017 Q3 | 1.69 Billion CNY | 1.56% |
| 2017 Q1 | 1.69 Billion CNY | 1.17% |
| 2016 FY | 1.67 Billion CNY | 21.3% |
| 2016 Q4 | 1.67 Billion CNY | 21.17% |
| 2016 Q3 | 1.38 Billion CNY | 2.6% |
| 2016 Q1 | 1.33 Billion CNY | -3.58% |
| 2016 Q2 | 1.34 Billion CNY | 1.2% |
| 2015 Q1 | 1.36 Billion CNY | -0.21% |
| 2015 FY | 1.38 Billion CNY | 0.92% |
| 2015 Q4 | 1.38 Billion CNY | 1.54% |
| 2015 Q3 | 1.35 Billion CNY | -1.06% |
| 2015 Q2 | 1.37 Billion CNY | 0.66% |
| 2014 Q4 | 1.36 Billion CNY | 3.49% |
| 2014 Q3 | 1.32 Billion CNY | 2.04% |
| 2014 Q2 | 1.29 Billion CNY | -2.75% |
| 2014 Q1 | 1.33 Billion CNY | 0.73% |
| 2014 FY | 1.36 Billion CNY | 3.45% |
| 2013 Q3 | 1.17 Billion CNY | 2.7% |
| 2013 FY | 1.32 Billion CNY | 26.9% |
| 2013 Q2 | 1.14 Billion CNY | 2.53% |
| 2013 Q1 | 1.11 Billion CNY | 6.73% |
| 2013 Q4 | 1.32 Billion CNY | 12.91% |
| 2012 Q2 | 1 Billion CNY | 3.11% |
| 2012 Q3 | 1.04 Billion CNY | 4.15% |
| 2012 Q4 | 1.04 Billion CNY | -0.73% |
| 2012 FY | 1.04 Billion CNY | 11.0% |
| 2012 Q1 | 977.33 Million CNY | 4.13% |
| 2011 Q1 | 952.97 Million CNY | 0.52% |
| 2011 Q4 | 938.59 Million CNY | 1.28% |
| 2011 FY | 938.59 Million CNY | -1.0% |
| 2011 Q2 | 899.43 Million CNY | -5.62% |
| 2011 Q3 | 926.72 Million CNY | 3.03% |
| 2010 Q2 | 921.62 Million CNY | 247.15% |
| 2010 Q4 | 948.05 Million CNY | 2.3% |
| 2010 Q3 | 926.76 Million CNY | 0.56% |
| 2010 Q1 | 265.48 Million CNY | 7.4% |
| 2010 FY | 948.05 Million CNY | 283.52% |
| 2009 Q2 | 222.82 Million CNY | 0.0% |
| 2009 Q4 | 247.19 Million CNY | 0.0% |
| 2009 FY | 247.19 Million CNY | 15.01% |
| 2008 FY | 214.92 Million CNY | 23.34% |
| 2007 FY | 174.25 Million CNY | -17.7% |
| 2006 FY | 211.73 Million CNY | 0.0% |